ERBB2 and breast carcinoma: The characterization includes the evaluation of TS-MSN physicochemical parameters, their potential to protect siRNA against degradation by RNAse, and their potential to downregulate the Survivin protein and mRNA expression on the HER2+ breast cancer cell line, SK-BR-3.